Hong Ching-Ye, Hughes Kenneth, Chia Kee-Seng, Ng Vivian, Ling Sing-Lin
Department of Community, Occupational and Family Medicine, National University of Singapore, Singapore.
Diabetes Care. 2003 Feb;26(2):338-42. doi: 10.2337/diacare.26.2.338.
This study examines urinary alpha(1)-microglobulin as a marker of early nephropathy in type 2 diabetic Chinese, Malays, and Asian Indians in Singapore.
A cross-sectional study was performed on 590 consecutive type 2 diabetic patients (296 males, 294 females) who were on routine follow-up at a primary care clinic. Information was obtained from interviews, case notes, and blood and urine samples. Because the distribution of urinary alpha(1)-microglobulin levels was highly skewed, these levels were log-transformed, and geometric means were calculated. There was correction for variability in urine flow by dividing by urine creatinine levels, given as mg/mmol urine creatinine, and adjustment for confounding variables.
Urinary alpha(1)-microglobulin was higher in men than in women and was directly related to age, but no ethnic differences were apparent. It was directly related to duration of diabetes, with adjusted geometric means of 1.19 and 1.43 mg/mmol urine creatinine for a duration of <10 and > or =10 years, respectively (P = 0.07). Urinary alpha(1)-microglobulin was highest in patients on insulin, followed by those on oral medication and then those on diet alone (adjusted geometric means: 1.47, 1.36, and 0.86 mg/mmol urine creatinine, respectively; P = 0.01). Levels were also higher in patients with poor glucose control, as measured by HbA(1c), fasting plasma glucose, and 2-h postprandial plasma glucose (P < 0.01 for each). Urinary alpha(1)-microglobulin was directly related to albuminuria, with adjusted geometric means for normoalbuminuria, microalbuminuria, and macroalbuminuria of 1.06, 1.47, and 4.72 mg/mmol urine creatinine, respectively (P < 0.01). However, of patients with normoalbuminuria, 33.6% had raised urinary alpha(1)-microglobulin. Likewise, of patients with normal urinary alpha(1)-microglobulin, 27.6% had albuminuria.
Urinary alpha(1)-microglobulin was related to duration, severity, and control of diabetes. Urinary alpha(1)-microglobulin and albumin were directly related, but in some patients, one was present in the absence of the other. Hence, in addition to albuminuria (which measures glomerular dysfunction), urinary alpha(1)-microglobulin (which measures proximal tubular dysfunction) is useful for the early detection of nephropathy in diabetic subjects.
本研究检测尿α1-微球蛋白作为新加坡华裔、马来裔和亚洲印度裔2型糖尿病患者早期肾病标志物的情况。
对一家基层医疗诊所进行常规随访的590例连续性2型糖尿病患者(296例男性,294例女性)开展横断面研究。通过访谈、病例记录以及血液和尿液样本获取信息。由于尿α1-微球蛋白水平分布高度偏态,对这些水平进行对数转换并计算几何均数。通过除以尿肌酐水平(以mg/mmol尿肌酐表示)校正尿流变异性,并对混杂变量进行调整。
男性尿α1-微球蛋白高于女性,且与年龄直接相关,但无明显种族差异。它与糖尿病病程直接相关,糖尿病病程<10年和≥10年的校正几何均数分别为1.19和1.43 mg/mmol尿肌酐(P = 0.07)。使用胰岛素的患者尿α1-微球蛋白最高,其次是使用口服药物的患者,然后是仅接受饮食治疗的患者(校正几何均数分别为:1.47、1.36和0.86 mg/mmol尿肌酐;P = 0.01)。通过糖化血红蛋白、空腹血糖和餐后2小时血糖衡量,血糖控制不佳的患者尿α1-微球蛋白水平也更高(每项P < 0.01)。尿α1-微球蛋白与蛋白尿直接相关,正常蛋白尿、微量蛋白尿和大量蛋白尿的校正几何均数分别为1.06、1.47和4.72 mg/mmol尿肌酐(P < 0.01)。然而,在正常蛋白尿患者中,33.6%的患者尿α1-微球蛋白升高。同样,在尿α1-微球蛋白正常的患者中,27.6%的患者有蛋白尿。
尿α1-微球蛋白与糖尿病的病程、严重程度及控制情况相关。尿α1-微球蛋白与白蛋白直接相关,但在一些患者中,两者之一存在时另一个并不存在。因此,除了蛋白尿(衡量肾小球功能障碍)外,尿α1-微球蛋白(衡量近端肾小管功能障碍)对于糖尿病患者肾病的早期检测也很有用。